BCL2 and breast cancer: Additionally, TRIM25 decreased the protein stability of BRD7 through the ubiquitin proteasome pathway by increasing the K48-linked ubiquitination of BRD7 at the K119 site, and then activated the YB1/Bcl-2 signal axis, thus mediating malignant progression and PTX resistance of breast cancer.